Assessment of Appropriate Use of Blood Products in a Tertiary Care Center in India- An Audit Study

Abstract

Anjali Sharma1 , Heena2 , Sunil Ranga3 , Rashmi Arora4

BACKGROUND The evolution of Patient Blood Management (PBM) has minimized the unnecessary use of blood products across the world. The present study was conducted to evaluate the appropriate usage of blood products in our institute. METHODS This study was conducted at a tertiary care hospital in New Delhi, India. This is a retrospective study and all the information regarding transfusion in different departments was collected from blood requisition forms. A total of 11,829 transfusions were evaluated in 5507 patients. The appropriate usage of blood products was assessed by WHO/NACO guidelines. RESULTS These patients received 11,882 transfusions (mean number of 2.21 transfusions per patient). Out of the total of 11882 requests of blood components among 5507 patients, 46.35% were of Packed Red Blood Cells (PRBC), 17.44% were of Fresh Frozen Plasma (FFP) and 36.21% requests were of platelet transfusions. The overall prevalence of appropriate demand of blood was 76.21% for all the departments. The most inappropriately used blood component was PRBC (34.37%), followed by FFP (17.47%) and platelets (13.29%) respectively. The most common cause of inappropriate use of PRBC was multiple units requested at same time without indication. Demand for FFP and platelets was inappropriate primarily due to unindicated transfusion demands and incompletely filled forms. CONCLUSIONS The present study emphasizes the importance of blood audit in the clinical setting. Prospective audits and bed site visits by a transfusion specialist has a key role in the implementation of Patient blood management programme.

image